ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 132 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,000 | -20.0% | 168 | 0.0% | 0.00% | -25.0% |
| Q1 2016 | $5,000 | +400.0% | 168 | +784.2% | 0.00% | +300.0% |
| Q4 2015 | $1,000 | -87.5% | 19 | -90.8% | 0.00% | -83.3% |
| Q3 2015 | $8,000 | -20.0% | 206 | 0.0% | 0.01% | -25.0% |
| Q2 2015 | $10,000 | +66.7% | 206 | 0.0% | 0.01% | +60.0% |
| Q1 2015 | $6,000 | -40.0% | 206 | +6.7% | 0.01% | -50.0% |
| Q4 2014 | $10,000 | – | 193 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |